Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
5
×
clinical trials
san francisco blog main
san francisco top stories
biotech ipos
boston
fda
investing
startups
biogen
blackstone group
cancer immunotherapy
david goldstein
deals
depression
epilepsy
essential tremor
kiran reddy
major depressive disorder
medicare
national
nonalcoholic steatohepatitis
perimenopausal depression
praxis precision medicines
steven petrou
89bio
abbvie
acute myeloid leukemia
adrian krainer
alexion pharmaceuticals
aligos therapeutics
alx oncology
alzheimer europe conference
What
research
5
×
biotech
drugs
medicines
new
aims
ipos
praxis
precision
week
alzheimer’s
annual
approach
arrival
assessed
attention
backed
based
bio
biotechs
called
cause
central
ceo
cns
communities
companies
conference
days
debuts
developing
disorder
drug
emerged
epigenetic
epigenetics
epilepsy
esmo
europe
field
Language
unset
Current search:
biotech
×
research
×
" new york top stories "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More